Related content

A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women

By Cigler T.  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 453-461

Springer Publishing Company

Access to resources Recommend Favorite

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Trial of JM-216 in Cervical Cancer: An NCIC CTG Study

By Trudeau M.   Stuart G.   Hirte H.   Drouin P.   Plante M.   Bessette P.   Dulude H.   Lebwohl D.   Fisher B.   Seymour L.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 327-331

Elsevier

Access to resources Recommend Favorite

Cerebral metastases from malignant fibrous histiocytoma of bone

By Rogers Susanne J.   Whelan Jeremy S.  

Sarcoma, Vol. 4, Iss. 3, 2000-09 ,pp. : 125-128

Informa Healthcare

Access to resources Recommend Favorite

Radiotherapy for bone metastases: Practice in Norway 1997–2007. A national registry-based study

By Laugsand Tonje Sande   Kaasa Stein   Romundstad Pål   Johannesen Tom Børge   Lund Jo-Åsmund  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1129-1136

Informa Healthcare

Access to resources Recommend Favorite